6.
Hattersley G, Dean T, Corbin B, Bahar H, Gardella T
. Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling. Endocrinology. 2015; 157(1):141-9.
PMC: 4701881.
DOI: 10.1210/en.2015-1726.
View
7.
Maass P, Wirth J, Aydin A, Rump A, Stricker S, Tinschert S
. A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to Brachydactyly Type E. Hum Mol Genet. 2009; 19(5):848-60.
PMC: 3031338.
DOI: 10.1093/hmg/ddp553.
View
8.
Ruschendorf F, Nurnberg P
. ALOHOMORA: a tool for linkage analysis using 10K SNP array data. Bioinformatics. 2005; 21(9):2123-5.
DOI: 10.1093/bioinformatics/bti264.
View
9.
Cheloha R, Gellman S, Vilardaga J, Gardella T
. PTH receptor-1 signalling-mechanistic insights and therapeutic prospects. Nat Rev Endocrinol. 2015; 11(12):712-24.
PMC: 4651712.
DOI: 10.1038/nrendo.2015.139.
View
10.
Schihada H, Shekhani R, Schulte G
. Quantitative assessment of constitutive G protein-coupled receptor activity with BRET-based G protein biosensors. Sci Signal. 2021; 14(699):eabf1653.
DOI: 10.1126/scisignal.abf1653.
View
11.
Pena K, White A, Savransky S, Portales Castillo I, Jean-Alphonse F, Gardella T
. Biased GPCR signaling by the native parathyroid hormone-related protein 1 to 141 relative to its N-terminal fragment 1 to 36. J Biol Chem. 2022; 298(9):102332.
PMC: 9437850.
DOI: 10.1016/j.jbc.2022.102332.
View
12.
Couvineau A, Wouters V, Bertrand G, Rouyer C, Gerard B, Boon L
. PTHR1 mutations associated with Ollier disease result in receptor loss of function. Hum Mol Genet. 2008; 17(18):2766-75.
PMC: 2722890.
DOI: 10.1093/hmg/ddn176.
View
13.
Ehrenmann J, Schoppe J, Klenk C, Rappas M, Kummer L, Dore A
. High-resolution crystal structure of parathyroid hormone 1 receptor in complex with a peptide agonist. Nat Struct Mol Biol. 2018; 25(12):1086-1092.
DOI: 10.1038/s41594-018-0151-4.
View
14.
Terkeltaub R, Lotz M, Johnson K, Deng D, Hashimoto S, Goldring M
. Parathyroid hormone-related proteins is abundant in osteoarthritic cartilage, and the parathyroid hormone-related protein 1-173 isoform is selectively induced by transforming growth factor beta in articular chondrocytes and suppresses generation of.... Arthritis Rheum. 1998; 41(12):2152-64.
DOI: 10.1002/1529-0131(199812)41:12<2152::AID-ART10>3.0.CO;2-X.
View
15.
Suva L, Friedman P
. PTH and PTHrP Actions on Bone. Handb Exp Pharmacol. 2020; 262:27-45.
DOI: 10.1007/164_2020_362.
View
16.
Mochizuki S, Okada Y
. ADAMs in cancer cell proliferation and progression. Cancer Sci. 2007; 98(5):621-8.
PMC: 11160018.
DOI: 10.1111/j.1349-7006.2007.00434.x.
View
17.
Sutkeviciute I, Clark L, White A, Gardella T, Vilardaga J
. PTH/PTHrP Receptor Signaling, Allostery, and Structures. Trends Endocrinol Metab. 2019; 30(11):860-874.
PMC: 6857722.
DOI: 10.1016/j.tem.2019.07.011.
View
18.
Cohen Jr M
. The new bone biology: pathologic, molecular, and clinical correlates. Am J Med Genet A. 2006; 140(23):2646-706.
DOI: 10.1002/ajmg.a.31368.
View
19.
Borner S, Schwede F, Schlipp A, Berisha F, Calebiro D, Lohse M
. FRET measurements of intracellular cAMP concentrations and cAMP analog permeability in intact cells. Nat Protoc. 2011; 6(4):427-38.
DOI: 10.1038/nprot.2010.198.
View
20.
Mann R, Wigglesworth M, Donnelly D
. Ligand-receptor interactions at the parathyroid hormone receptors: subtype binding selectivity is mediated via an interaction between residue 23 on the ligand and residue 41 on the receptor. Mol Pharmacol. 2008; 74(3):605-13.
DOI: 10.1124/mol.108.048017.
View